Yefur 250 Tablet contains Cefuroxime 250 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, otitis media, and Lyme disease. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Yefur 250 is administered orally and exhibits good bioavailability, with peak plasma concentrations achieved within 2 to 3 hours post-dose. It is generally well tolerated; however, potential adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, as well as hypersensitivity reactions in patients with a history of penicillin or cephalosporin allergy. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Yefur 250 should be used strictly according to susceptibility patterns to minimize the development of resistance. It is contraindicated in individuals with known hypersensitivity to cefuroxime or other beta-lactam antibiotics. Proper adherence to prescribed duration and dosage is essential to ensure therapeutic efficacy and prevent recurrence of infection.